Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Market Access

Medicare Advantage Insurers Will See Higher Payments as CMS Backs Off a Key Payment Update

 April 8, 2026

KFF Medicare

The Trump administration this week backed off a key element of its Medicare Advantage rate proposal, resulting in billions of dollars in additional payments to private insurers.

Market AccessRead full story

Post navigation

Sidewinder pockets $137m in Series B to take bispecific ADCs to clinic →
← Gilead Less M&A Happy Now but Door Still Open for ‘Compelling’ Opportunities

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com